Peripheral Lung Lesions
Conditions
Brief summary
The goal of this clinical trial is to evaluate the diagnostic efficacy and safety of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology in peripheral lung lesions. The main question it aims to answer are: the effectiveness and safety of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology. Participants will undergo CT-guided percutaneous lung biopsy or percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology.
Interventions
PROCEDURECT-guided percutaneous lung biopsy
The participants would undergo CT-guided percutaneous lung biopsy.
PROCEDUREPercutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology
The participants would undergo percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology.
Sponsors
China-Japan Friendship Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Age 18-80 years old * Imaging examination showed peripheral lung lesions * Selected patients need to complete routine preoperative examinations such as blood routine examination, coagulation function, electrocardiogram, chest CT, etc * There is no contraindication for puncture biopsy * Good compliance, able to cooperate with research and observation * Fully informed of the purpose and method of the study, agreed to participate in the study, and signed the informed consent form
Exclusion criteria
* Severe cardiopulmonary insufficiency, extreme weakness and intolerance of patients * The patient is allergic to lidocaine and midazolam * The site to be biopsied has a high risk of bleeding such as bronchial artery penetration or suspected lung metastasis of renal cancer * Unstable angina pectoris, congestive heart failure, severe bronchial asthma * The patient did not agree to participate in the study * Participation in other studies within three months without withdrawal or termination will affect the observation of this study * The researcher believes that there is any person who is not suitable for the selection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diagnostic accuracy of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology for diagnosis of pleural effusion. | 7 days after the lung biopsy | The diagnosis would be confirmed according to the pathological results or multidisciplinary discussion results (if interstitial lung disease is suspected, the multidisciplinary discussion results shall be recorded). The diagnostic efficacy of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology will be compared with that of CT-guided percutaneous lung biopsy for diagnosis of pleural effusion. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Operation time | during the operation of lung biopsy | Timer |
Contacts
Primary ContactMingming Deng, MD
Outcome results
None listed